Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.32 |
| ▸ | TARBP2 | Q15633 | 1/20 | 0.31 |
| ▸ | AKT1 | P31749 | 1/20 | 0.31 |
| ▸ | AKT2 | P31751 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.30 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.30 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15302545 | 0.90 | MEN1 (0.32) | L3MBTL1 | |
| SCHEMBL1308621 | 0.84 | ALDH1A1 (0.34) | L3MBTL1KDM4EALDH1A1MAPTTAAR1 | |
| SCHEMBL4272275 | 0.84 | ALDH1A1 (0.41) | L3MBTL1SMN1; SMN2HPGDNPC1RAB9A | |
| SCHEMBL12112058 | 0.84 | MAPT (0.33) | MAPT | |
| SCHEMBL14956699 | 0.83 | MEN1 (0.30) | — | |
| SCHEMBL12112054 | 0.83 | HSD17B10 (0.38) | L3MBTL1SMN1; SMN2HPGDNPC1RAB9A | |
| SCHEMBL1305375 | 0.80 | ALDH1A1 (0.38) | ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA7 | |
| SCHEMBL1308149 | 0.80 | ESR1 (0.41) | SMN1; SMN2ALDH1A1TP53MAPTOPRD1 | |
| SCHEMBL1306585 | 0.80 | NR1H2 (0.31) | — | |
| SCHEMBL1305649 | 0.80 | RELA (0.36) | SMN1; SMN2HPGDNPC1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7608673-B2 | Organosilane compound and organosilica obtain therefrom | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2009-10-27 | — | — | US | disclosed |
| US-7608673-B2 | Organosilane compound and organosilica obtain therefrom | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2009-10-27 | — | — | US | disclosed |
| US-20080227941-A1 | Organosilane compound and organosilica obtained therefrom | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2008-09-18 | — | — | US | disclosed |
| US-20080227941-A1 | Organosilane compound and organosilica obtained therefrom | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2008-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227941-A1 | Organosilane compound and organosilica obtained therefrom | OR51E2, WEE1, WEE2 | L3MBTL1 864/4885SMN1; SMN2 4683/4885HPGD 3720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.